麦科田(02041)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02041 麦科田

交易中 10-15 13:07:50

6.935

-0.145

-2.05%

最高7.425	最低6.900	成交量15.48万
今开7.080	昨收7.080	日振幅7.42%
总市值37.35亿	流通市值33.23亿	总股本5.39亿
成交额109.39万	换手率0.03%	流通股本4.79亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02041","market":"HK","secType":"STK","nameCN":"麦科田","latestPrice":6.935,"timestamp":1792040639436,"preClose":7.08,"halted":0,"volume":154800,"delay":0,"changeRate":-0.02048022598870063,"floatShares":479221686,"shares":538626686,"eps":0.105,"marketStatus":"交易中","change":-0.145,"latestTime":"10-15 13:07:50","open":7.08,"high":7.425,"low":6.9,"amount":1093948,"amplitude":0.074153,"askPrice":6.94,"askSize":600,"bidPrice":6.93,"bidSize":500,"shortable":0,"etf":0,"ttmEps":0.02,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1792051800000},"marketStatusCode":2,"adr":0,"listingDate":1788710400000,"exchange":"SEHK","adjPreClose":7.08,"openAndCloseTimeList":[[1792027800000,1792036800000],[1792040400000,1792051200000]],"volumeRatio":0.816266,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02041","defaultTab":"news","newsList":[{"id":"2674990128","title":"麦科田中报：拨开利润波动迷雾，读懂器械龙头的真实底色","url":"https://stock-news.laohu8.com/highlight/detail?id=2674990128","media":"美港探案","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674990128?lang=zh_cn&edition=full","pubTime":"2026-10-10 16:17","pubTimestamp":1791620220,"startTime":"0","endTime":"0","summary":"今天抛开市场杂音，纯粹从个人复盘角度，拆解麦科田中报被严重低估的核心逻辑。剔除干扰后，麦科田的主业基本面不仅没崩，反而持续走强。上半年30款介入耗材拿下欧盟认证，多款高端内镜新品获批上市，高毛利产品持续放量，正在彻底改写板块盈利结构。麦科田，是为数不多真正跑通海外商业模式的国产企业。最后总结整体复盘下来，麦科田这份中报，妥妥的被市场情绪错杀。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzIzNDE1NDIyMg==&mid=2653420756&idx=1&sn=9c9473ebf4523281c72642ebf1b0e5cb&chksm=f2d54f6693b2ddb1d5b65e6b0c3c2a7616e9f12ecac3f5b3706436d5fd8fe3ebc2527445ad5b&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["02041","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120141191","title":"麦科田2026年9月股份变动月报：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1120141191","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120141191?lang=zh_cn&edition=full","pubTime":"2026-10-06 18:02","pubTimestamp":1791280926,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司于2026年10月6日披露截至2026年9月30日的股份变动月报。报告显示，公司注册股本合计为538,626,686股，共包含479,221,686股H股及59,405,000股未上市境内股份，与上月末保持一致。公司披露已于2024年12月16日通过并采纳首次公开发售前购股权计划，合计授出23,872,500份购股权，本月内无行使、授予或失效的情况。公司确认，其已遵守香港联交所《上市规则》及其他适用的法律法规，本月股本整体保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192465692","title":"麦科田（02041）完成3,891.06万股H股发行 注册资本增至538,626,686元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192465692","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192465692?lang=zh_cn&edition=full","pubTime":"2026-09-28 21:21","pubTimestamp":1790601711,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司9月28日在港交所公告称，鉴于公司已完成H股发行并于2026年9月7日在香港联合交易所主板上市，其第二届董事会第十次会议审议通过了变更注册资本并修订公司章程的议案。发行完成后，公司股本总额由499,716,086股增至538,626,686股，相应注册资本由人民币499,716,086元增加至人民币538,626,686元。其中，境内未上市股份59,405,000股，占总股本的11.03%；H股普通股479,221,686股，占总股本的88.97%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192873003","title":"麦科田2026年中期营收9.00亿元，经调整净利润76.24百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192873003","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192873003?lang=zh_cn&edition=full","pubTime":"2026-09-28 21:13","pubTimestamp":1790601197,"startTime":"0","endTime":"0","summary":"麦科田公布2026年中期业绩，报告期内实现营收9.00亿元，同比增长14.4%。经调整净利润录得76.24百万元，同比增长9.8%。毛利率升至54.5%，上一年同期为52.9%。经营活动现金流达1.00亿元，同比提升73.7%。同时，在参与第七批集中带量采购后，虽然短期内相关产品价格及毛利率可能承受一定压力，但麦科田计划通过产能规模扩张和运营效率提升，进一步推动销售量增长，争取保持高质量的业务增长。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"麦科田2026年中期营收9.00亿元，经调整净利润76.24百万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195451371","title":"麦科田：Zhuhai Gao Ling Tiancheng Equity Investment Fund (Limited Partnership)增持，好仓比例升至39.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1195451371","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195451371?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:50","pubTimestamp":1790070645,"startTime":"0","endTime":"0","summary":"于2026年9月7日因麦科田（02041）未上市股份上市而取得股份，该交易属股份上市相关的初始披露，并非在联交所公开市场直接买卖。Zhuhai Gao Ling Tiancheng Equity Investment Fund (Limited Partnership)此次增持前持有麦科田好仓0股，占比0%；增持后持股量为2337.50万股，好仓比例升至39.35%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119231090","title":"麦科田：Tianjin Zhenying Enterprise Management Consultancy Limited Partnership (Limited Partnership)增持，好仓比例升至38.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119231090","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119231090?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:32","pubTimestamp":1790069552,"startTime":"0","endTime":"0","summary":"根据香港交易所披露，Tianjin Zhenying Enterprise Management Consultancy Limited Partnership (Limited Partnership) 于2026年9月7日因麦科田股份上市而持有好仓2310.00万股，占已发行股份的38.89%。该申报人此次增持前未持有任何麦科田好仓，增持后持股量为2310.00万股，好仓比例升至38.89%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118091401","title":"麦科田：Zhuhai Aiheng Equity Investment Partnership (Limited Partnership)增持，好仓比例升至6.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118091401","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118091401?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:15","pubTimestamp":1790068524,"startTime":"0","endTime":"0","summary":"Zhuhai Aiheng Equity Investment Partnership (Limited Partnership)于2026年9月7日增持麦科田（02041）398.75万股（股份类别：其他），该增持系因公司上市相关股份发行，并非在联交所公开市场直接买卖。Zhuhai Aiheng Equity Investment Partnership (Limited Partnership)此次增持前持有麦科田好仓0股，占比0%；增持后持股量为398.75万股，好仓比例升至6.71%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103379888","title":"麦科田(02041)公告推行电子化公司通讯安排 9月18日起实施","url":"https://stock-news.laohu8.com/highlight/detail?id=1103379888","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103379888?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:50","pubTimestamp":1789721458,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司（股票代码：02041）于2026年9月18日发布公告称，依据香港联合交易所有限公司证券上市规则，公司已采用以电子方式发布公司通讯的安排。自该日起，所有未来公司通讯将以网站版本形式刊载于公司网站（www.medcaptain.com）及香港联合交易所有限公司披露易网站（www.hkexnews.hk），除非股东提出另外要求，否则将不再发送纸质文件。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164039152","title":"麦科田（02041）发布公司通讯电子化安排 自2026年9月18日起实施","url":"https://stock-news.laohu8.com/highlight/detail?id=1164039152","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164039152?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:35","pubTimestamp":1789720543,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司9月18日公告，根据香港联合交易所有限公司证券上市规则第2.07A条及公司章程细则，自2026年9月18日起，公司将通过电子方式向股东发送后续公司通讯，并仅在股东提出要求时提供纸质版本。公告显示，麦科田未来对“可供采取行动的公司通讯”将采用电子邮件个别发送。如有任何疑问，股东可于工作日9:00－18:00致电卓佳证券登记有限公司，电话 2980 1333，或发送邮件至2041-ecom@vistra.com。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103613100","title":"麦科田(02041)拟于2026年9月28日召开董事会审议中期业绩及分红方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1103613100","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103613100?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:41","pubTimestamp":1789555276,"startTime":"0","endTime":"0","summary":"麦科田9月16日公告称，公司董事会已决定于2026年9月28日（星期一）召开会议，主要议程包括：。公告显示，会议将由董事长兼执行董事刘傑先生主持。截至公告日，董事会成员构成为：。公司提醒投资者关注后续公告，以及时了解董事会会议结果及中期业绩详情。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667811576","title":"麦科田港股破发背后：盈利持续性不稳定，高商誉与渠道集中藏隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2667811576","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667811576?lang=zh_cn&edition=full","pubTime":"2026-09-13 15:00","pubTimestamp":1789282800,"startTime":"0","endTime":"0","summary":"截至9月10日收盘，麦科田股价较发行价下跌41.57%。高商誉与渠道集中，是其上市后需要面对的课题。9月7日，麦科田正式在港股挂牌上市交易。然而上市首日，麦科田开盘便破发，未能迎来开门红。2025年，麦科田扭亏为盈，归属净利润5073.8万元。麦科田上市首日股价大幅破发，显示资本市场对其估值与盈利持续性持审慎态度。麦科田称，经销商数目大致与销售计划及区域市场需求一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjyj/2026-09-13/doc-inirsqpy4499654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","02041","BK4585","VXUS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666938544","title":"麦科田赴港上市：并购拼出的医疗器械版图，暗藏多重隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2666938544","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666938544?lang=zh_cn&edition=full","pubTime":"2026-09-11 15:35","pubTimestamp":1789112100,"startTime":"0","endTime":"0","summary":"近日，麦科田正式开启港股全球发售。盈利脆弱性在 2026 年一季度进一步暴露，上市前夕再度出现 252.7 万元亏损。靠并购快速拼出业务版图的麦科田，即将站上港股资本市场。对于麦科田而言，如何完成并购资产的深度整合、夯实自主研发实力、化解商誉与渠道危机，将决定它能否从并购拼凑的企业，蜕变为具备内生竞争力的医疗器械公司。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5385233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["KCE","MYLD","IEIH","RSPH","GDOC","BK1574","BK1583","HART","BK1100","PTH","MEDX","BK4588","LGHT","MDEV","159883","LNGR","02041","09996","XMMO","AGNG","CALF","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666264569","title":"麦科田港股破发背后：盈利持续性不稳定，高商誉与渠道集中藏隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2666264569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666264569?lang=zh_cn&edition=full","pubTime":"2026-09-10 17:05","pubTimestamp":1789031132,"startTime":"0","endTime":"0","summary":"截至9月10日收盘，麦科田股价较发行价下跌41.57%。高商誉与渠道集中，是其上市后需要面对的课题。9月7日，麦科田正式在港股挂牌上市交易。回溯麦科田的发展历程，业务扩张主要与其持续对外收购的战略密切相关。2025年，麦科田扭亏为盈，归属净利润5073.8万元。麦科田上市首日股价大幅破发，显示资本市场对其估值与盈利持续性持审慎态度。麦科田称，经销商数目大致与销售计划及区域市场需求一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026091000030005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311166","title":"高瓴重仓，麦科田上市首日跌超40%！多位高管出身迈瑞医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311166","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665311166?lang=zh_cn&edition=full","pubTime":"2026-09-07 20:24","pubTimestamp":1788783878,"startTime":"0","endTime":"0","summary":"9月7日，深圳麦科田生物医疗技术股份有限公司（简称“麦科田”）正式在港交所主板挂牌上市。然而，这家被高瓴资本重仓押注的企业，并未迎来开门红。上市首日，麦科田开盘即破发，截至收盘报8.8港元/股，较发行价15.43港元大跌42.93%，总市值47.4亿港元。官网显示，麦科田成立于2011年，是一家立足中国的全球化医疗器械提供商。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866884520.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866884520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1064130708.USD","LU1794554557.SGD","LU0327786744.USD","LU1064131003.USD","LU1781817850.SGD","LU2148510915.USD","LU1979443071.USD","LU0605514214.HKD","LU0823426308.USD","LU2348774022.SGD","LU1734074674.USD","BK0251","LU1997245177.USD","LU0405327494.USD","300760","IE0031814852.USD","LU0084288322.USD","LU1820825898.SGD","IE00B031HY20.USD","LU1023057109.AUD","SGXZ49509284.SGD","LU1720050803.USD","LU0359201612.USD","IE0008368742.USD","LU0650527681.SGD","LU2153591404.USD","LU0572944931.SGD","LU1580142542.USD","SGXZ81163826.USD","LU0594300419.USD","02041","LU1688375341.USD","LU1997245094.SGD","LU2348773727.SGD","IE00B29SXG58.USD","LU2213484517.USD","IE0005HP3H50.USD","LU2424517915.HKD","LU1655091616.SGD","LU2488822045.USD","IPOS","LU0594300179.USD","LU1934453819.USD","LU2153592121.USD","LU0405327148.USD","LU0823426480.USD","LU1146622755.USD","LU0359202008.SGD","IE00B031J352.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317259","title":"欢迎麦科田医疗（2041.HK）今日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317259","media":"香港交易所脈搏/HKExPulse","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665317259?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:31","pubTimestamp":1788773460,"startTime":"0","endTime":"0","summary":"< 左右滑动查看更多 >今天，我们欢迎深圳麦科田生物医疗技术股份有限公司（2041.HK）登陆香港资本市场。麦科田医疗是一家医疗器械提供商，致力于推动生命支持、微创介入和体外诊断三大领域的创新。我们祝贺麦科田医疗#上市，并期待支持其持续发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA4ODAxMzAyMA==&mid=2664983726&idx=1&sn=ec2ee833679d17d08de09ec3ff6d7c30&chksm=8a4086598023bc64c5c63334bf615fba1beb58704b18c7a4f9cc56f9c3511ce8579b0640aa3a&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102415277","title":"异动解读｜麦科田盘中下跌34.57%，首日挂牌大幅破发","url":"https://stock-news.laohu8.com/highlight/detail?id=1102415277","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102415277?lang=zh_cn&edition=full","pubTime":"2026-09-07 13:20","pubTimestamp":1788758439,"startTime":"0","endTime":"0","summary":"9月7日，麦科田正式登陆港交所主板，盘中下跌34.57%，报10.09港元，成交额1.0亿港元。消息面上，麦科田今日首挂即破发，开盘报10.00港元，较招股价15.42港元低约35%。此前暗盘阶段股价已跌超17%，市场对其定价存在较大分歧。深圳麦科田生物医疗技术股份有限公司是一家全球医疗器械提供商，业务涵盖生命支持、微创介入及体外诊断三大板块，产品销往全球逾140个国家及地区。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"麦科田首日挂牌，大幅破发","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399736","title":"【新股IPO】麦科田（02041）首挂破发 午后较招股价低超34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399736","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665399736?lang=zh_cn&edition=full","pubTime":"2026-09-07 13:13","pubTimestamp":1788757995,"startTime":"0","endTime":"0","summary":"金吾财讯 | 麦科田（02041）首日挂牌惟表现欠佳，午后维持于低位，最新报10.06港元，较招股价低34.76%，成交额9881.2万港元。今早首挂开报10.00港元，较招股价低14.77%，每股100股，不计手续费，账面亏损542元。据招股结果，股份最终发售价厘定为每股15.42港元，香港公开发售获大幅超额认购，有效申请57,305份，认购倍数约436.37倍，一手中签率为5.00%。国际发售获适度超额认购，认购倍数约2.35倍。","market":"fut","thumbnail":"https://static.szfiu.com/news/20220324/OTU4MzQ2OThiZDJjMjUyYzEwMTY0ODA5MDg2MDM1OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/OTU4MzQ2OThiZDJjMjUyYzEwMTY0ODA5MDg2MDM1OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990891","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","KCE","FRHC","IPOS","REDS","02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399738","title":"麦科田港股上市破发：大跌34% 公司市值54亿港元 高瓴是股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399738","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665399738?lang=zh_cn&edition=full","pubTime":"2026-09-07 13:08","pubTimestamp":1788757708,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司（简称：“麦科田”，股票代码：“02041”）今日在港交所上市。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260907/6392438315044792244879915.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260907/6392438315044792244879915.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35086/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["KCAI","BK4588","BK4585","02041","VXUS","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665298390","title":"麦科田正式登陆港交所，市值逾53亿港元，全球一体化医疗器械提供商","url":"https://stock-news.laohu8.com/highlight/detail?id=2665298390","media":"独角兽早知道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665298390?lang=zh_cn&edition=full","pubTime":"2026-09-07 09:54","pubTimestamp":1788746040,"startTime":"0","endTime":"0","summary":"每股发售价15.42港元，全球发售净筹约4.96亿港元。今日开盘，麦科田报10.00港元/股，市值53.86亿港元。麦科田的产品组合覆盖超过60种生命支持产品、110种微创介入产品及150种体外诊断产品，已累计遍及全球逾140个国家及地区。同期，公司毛利从6.51亿元提升至8.70亿元，毛利率从49.6%提升至53.7%，2026年第一季度进一步升至54.3%。经调整净利润达1.29亿元。本次IPO所得款项净额约4.96亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU3MTY1MzExOQ==&mid=2247613461&idx=1&sn=b37d92af171ca22ddff9d6d524470d7d&chksm=fd705dda300e8c861fbe41603a3187bdcdc51047743ad008e0fa3dab62c499a2d55a1bd58a67&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK1100","BK1583","LGHT","LNGR","MEDX","AGNG","RSPH","MDEV","02041","GDOC","HART","09996","BK1574","PTH","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665393974","title":"麦科田(02041)正式登陆港交所 三大业务协同打造港股医疗设备板块又一标杆","url":"https://stock-news.laohu8.com/highlight/detail?id=2665393974","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665393974?lang=zh_cn&edition=full","pubTime":"2026-09-07 09:42","pubTimestamp":1788745371,"startTime":"0","endTime":"0","summary":"凭借生命支持、微创介入、体外诊断三大业务板块的协同布局，公司有望成为港股医疗设备板块的又一标杆。作为一家全球医疗器械提供商，麦科田可满足医疗机构内广泛的临床科室、病房和诊所以及社区卫生中心、检验机构和家庭护理场景的临床需求。麦科田此次登陆港股，标志着这家深耕医疗器械赛道十余年的平台型企业正式迈入资本市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492582.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HEXmain","159557","02041"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://www.medcaptain.com","stockEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":-0.1423},{"period":"3month","weight":-0.5409},{"period":"ytd","weight":-0.5409}],"compareEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":-0.0242},{"period":"3month","weight":-0.0278},{"period":"6month","weight":-0.0706},{"period":"1year","weight":-0.0443},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"深圳麦科田生物医疗技术股份有限公司是一家主要提供医疗器械产品的中国公司。该公司通过三个分部开展业务。生命支持产品分部主要提供先进输注设备、麻醉设备及相关耗材的完整集成。微创介入产品分部主要提供专为内窥镜手术设计的医疗器械。体外诊断（IVD）医疗器械分部主要提供无缝集成的尖端医疗检测设备与定制试剂。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"麦科田","nameEN":"MEDCAPTAIN"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"麦科田(02041)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供麦科田(02041)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"麦科田,02041,麦科田股票,麦科田股票老虎,麦科田股票老虎国际,麦科田行情,麦科田股票行情,麦科田股价,麦科田股市,麦科田股票价格,麦科田股票交易,麦科田股票购买,麦科田股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"麦科田(02041)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供麦科田(02041)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}